Owens Angela B, Canas Linda C, Russell Kevin L, Neville James S, Pavlin Julie A, MacIntosh Victor H, Gray Gregory C, Gaydos Joel C
U.S. Air Force School of Aerospace Medicine, Brooks City-Base, Texas 78235, USA.
Am J Prev Med. 2009 Sep;37(3):235-41. doi: 10.1016/j.amepre.2009.04.022.
The Department of Defense (DoD) Global Laboratory-Based Influenza Surveillance Program was initiated in 1997 to formally consolidate and expand existing influenza surveillance programs within the DoD and in areas where DoD was working. Substantial changes in 2008 provided an opportunity to review the operation of the surveillance program as it existed during seven complete influenza seasons (1998-2005); the review was conducted in 2008. A unique aspect of the DoD program was the global reach for specimen collection and the ability to rapidly ship, process, and evaluate specimens from 27 countries. The resulting epidemiologic data combined with the culture results from >46,000 patients provided information that was shared with similar national and international programs, such as those of the CDC. Likewise, selected influenza isolates were molecularly characterized and shared with the CDC to be compared with other surveillance programs. Timeliness of the samples contributed to the information available for annual influenza vaccine selection.
美国国防部（DoD）基于实验室的全球流感监测项目始于1997年，旨在正式整合并扩大国防部内部以及国防部开展工作地区现有的流感监测项目。2008年的重大变革为审视该监测项目在七个完整流感季节（1998 - 2005年）期间的运作情况提供了契机；此次审视于2008年进行。国防部项目的一个独特之处在于其标本采集的全球范围以及从27个国家快速运送、处理和评估标本的能力。由此产生的流行病学数据与来自46000多名患者的培养结果相结合，提供了与疾病控制与预防中心（CDC）等类似的国家和国际项目共享的信息。同样，选定的流感毒株进行了分子特征分析，并与疾病控制与预防中心共享，以便与其他监测项目进行比较。样本的及时性为每年流感疫苗的选择提供了可用信息。
